 NewLink Genetics
is a biopharmaceutical company applying innovative techniques in cancer
biology to produce new diagnostic and therapeutic agents to improve the
lives of cancer patients. Our work currently focuses on the following two technologies:
HyperAcute® Cancer Vaccines
Small Molecule (IDO-Inhibitors)
|
